Pharmacotherapeutic management of comorbid polycystic ovary syndrome and diabetes. (22nd November 2018)

• Record Type: Journal Article
• Authors: Ortiz-Flores, Andrés E.; Luque-Ramírez, Manuel; Escobar-Morreale, Héctor F.
• Is Part Of: Expert opinion on pharmacotherapy. Volume 19:Number 17(2018)
• Page Start: 1915
• Page End: 1926
• Publication Date: 2018-11-22
• Subjects: Diabetes -- glucose intolerance -- insulin resistance -- insulin sensitizers -- metformin -- oral antidiabetic drugs -- polycystic ovary syndrome; Chemotherapy -- Periodicals; 615.5805
• DOI: 10.1080/14656566.2018.1528231
• Languages: English
• ISSNs: 1465-6566

Abstract

ABSTRACT: Introduction : Polycystic ovary syndrome (PCOS) is a common endocrine disorder in premenopausal women. Insulin resistance and glucose intolerance are very prevalent metabolic complications in women with PCOS, especially in those presenting with weight excess. Therapeutic strategies targeting insulin resistance in PCOS are of interest because of their overall safety and their beneficial effects on metabolic and reproductive features. Areas covered : The authors review systematically all of the available therapeutic interventions targeting insulin resistance and/or disturbances of glucose metabolism in women with PCOS. Expert opinion : The diagnosis of glucose tolerance disorders in women with PCOS requires an oral glucose tolerance test. Strategies addressing weight excess and abdominal adiposity, from lifestyle modification to insulin sensitizers, may improve insulin resistance and glucose tolerance in women with PCOS. However, amelioration of signs and symptoms of PCOS usually requires the loss of large amounts of weight for it to be noticeable. Bariatric surgery has emerged as the most successful approach for obese patients with PCOS, because glucose intolerance, diabetes, and PCOS resolve in most cases through follow-ups. At present, the role of novel drugs targeting insulin resistance and/or diabetes such as inositols, berberine, resveratrol, and incretin-based therapies are yet to be properly established.